Article Information
History
- September 19, 2022.
Article Versions
- Version 1 (September 16, 2022 - 19:50).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Daniel J. Sheward1,2,
- Changil Kim1,
- Julian Fischbach1,
- Sandra Muschiol1,
- Roy A. Ehling3,
- Niklas K. Björkström4,
- Gunilla B. Karlsson Hedestam1,
- Sai T. Reddy3,
- Jan Albert1,
- Thomas P. Peacock5 and
- Ben Murrell1,*
- 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
- 2Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 3Department of Biosystems Science and Engineering, ETH Zürich
- 4Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 5Department of Infectious Disease, Imperial College London, London, UK
- ↵*Corresponding author; email: benjamin.murrell{at}ki.se
Posted September 19, 2022.
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
